Biolife Solutions Inc Stock
Your prediction
Biolife Solutions Inc Stock
The Biolife Solutions Inc stock is trending slightly upwards today, with an increase of €0.20 (0.770%) compared to yesterday's price.
Pros and Cons of Biolife Solutions Inc in the next few years
Pros
?
B****
?
S********** s********
?
W********* I********* f** t** n*** y****
Cons
?
C******** o* t** e**********
?
G***** c******* t* c**********
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Biolife Solutions Inc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Biolife Solutions Inc | 0.770% | 3.937% | 5.600% | 38.947% | 25.714% | 51.724% | -29.712% |
| Pacira Pharmaceuticals | -1.720% | 2.703% | 2.703% | 21.925% | 5.556% | -29.193% | -53.279% |
| Supernus Pharmaceuticals | 3.000% | -1.932% | -1.456% | 42.958% | -5.581% | 50.370% | 78.070% |
| Collegium Pharmaceutical Inc | -0.640% | -0.645% | 2.667% | 14.925% | -25.604% | 59.585% | 50.980% |
News
Repligen Q2 Earnings Call Highlights
Key Points
- Interested in Repligen Corporation? Here are five stocks we like better.
- Strong second-quarter performance: Repligen reported $204 million in revenue, up 12% year over year and 13%
Repligen to Buy BioLife Solutions for $1.5 Billion, Expanding Cell Therapy Reach
Key Points
- Interested in Repligen Corporation? Here are five stocks we like better.
- Repligen is acquiring BioLife Solutions in a deal valued at about $1.5 billion, paying $31 per share in a